Prepare for your visit

Amanda Schilly

Women's Health (Nurse Practitioner) · Saint Louis, MO · NPI 1467902742

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$7,689.13

in general payments reported to CMS, 2019-2025 · $2,333 in 2025

The $2,333 reported for 2025 was more than what 99% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).

Who reported paying

General payments only, top 6 by amount.

Biogen, INC. $1,288.00
Abbvie INC. $1,054.63
Mayne Pharma Commercial LLC $816.33
Evofem Biosciences, INC. $629.25
Amgen INC. $529.94
Astellas Pharma US INC $491.14

Drugs and devices associated with these payments

Zurzuvae Phexxi Myfembree Veozah Aptima Thinprep 2000 Processor Third Wave Wegovy Solosec Phexx Ubrelvy Evenity

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Amanda Schilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10957350/amanda-schilly